Cbay stock price forecast
CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CBAY updated stock price target summary. ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed CymaBay Therapeutics. CBAY. Delayed Nasdaq - 03/13 04:00:00 pm. 1.59 5 days ago On average, stock market experts give CBAY an Overweight rating. The average 12-month price forecast for this stock is $1.41, with the high Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and
CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
12 analysts have issued 1 year price objectives for CymaBay Therapeutics' shares. Their forecasts range from $1.50 to $18.00. On average, they anticipate CymaBay Therapeutics' share price to reach $5.81 in the next year. This suggests a possible upside of 309.2% from the stock's current price. View analysts' price targets for CymaBay Therapeutics. CBAY - Cymabay Therapeutics Inc Stock quote - CNNMoney.com Find real-time CBAY - Cymabay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. CBAY Stock Price | CymaBay Therapeutics Inc. Stock Quote ... CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
CBAY Buy or Sell? CBAY Buy or Sell?Find out if you should buy CBAY stock. Get a free CBAY technical analysis report to make a better CBAY stock predictions on how the stock will perform in the near future. The CBAY stock forecast is provided by MarketClub with …
Real time eBay (EBAY) stock price quote, stock graph, news & analysis. Real time eBay (EBAY) stock price quote, stock graph, news & analysis. The Motley Fool helps millions of people attain
CBAY: CymaBay Therapeutics Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for CymaBay Therapeutics Inc. from Zacks Investment Research company's stock price along
CBAY Price Target | CymaBay Therapeutics Stock Forecast ... See CymaBay Therapeutics price target based on 6 analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $2.78 with a high forecast of $4.00 and a low forecast of $1.50. The average price target represents a 97.16% increase from the last price of $1.41. CymaBay Therapeutics (NasdaqGS:CBAY) - Share price, News ... Should you invest in CymaBay Therapeutics (NasdaqGS:CBAY)? Flawless balance sheet and overvalued. Last updated 2020/03/29 03:19 How has CymaBay Therapeutics's share price performed over time and what events caused price changes? How is CymaBay Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 9 analysts? CBAY - Cymabay Therapeutics Stock Price History - Barchart.com End-of-Day historical data is available for up to two years prior to today's date. For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Download tab.Additional underlying chart data and study values can be downloaded using the Interactive Charts. CymaBay Therapeutics, Inc. (CBAY) Down -6.36%: Why This ...
Business and Financial News - CNN Money
A Great Stock That Is Lost For Many Investors: CymaBay ...
View today's stock price, news and analysis for CymaBay Therapeutics Inc. ( CBAY). Barron's also provides information on historical stock ratings, target prices, Mar 17, 2020 Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CBAY Oct 1, 2019 The average target price is $18.20, about 30% higher than where it is currently trading. Compare Brokers. Ulta Beauty (ULTA). Ulta Mar 6, 2020 (NASDAQ:CBAY) is now rated as Neutral. Their price target on the stock stands at $2. Even though the stock has been trading at $1.84/share, The successful prediction of a stock's future price could yield significant profit. The efficient-market hypothesis suggests that stock prices reflect all currently